RxDoctor Payments Data

Lauren Yunker

Physician Assistant · Hyde Park, NYNPI 1629291521

Payments from drug & device makers

$13,267in general payments, 2019–2025

Across 707 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Novo Nordisk$2K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • GSK$1K
  • Pfizer$882
  • plus $4K from 30 others

What the payments were for

  • Food & beverage$13,18499%
  • Education$821%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,267 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide68$94,060
OzempicSemaglutide18$39,405
FarxigaDapagliflozin Propanediol48$38,096
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$37,049
JardianceEmpagliflozin21$28,362
RybelsusSemaglutide15$25,717
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$22,198
EliquisApixaban23$18,604
JanuviaSitagliptin Phosphate13$17,254
Atorvastatin Calcium190$1,500
Levothyroxine Sodium109$1,484
Metoprolol Succinate54$1,251
Omega-3 Acid Ethyl Esters16$1,193
Valsartan27$1,102
Albuterol Sulfate HfaAlbuterol Sulfate28$1,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$1,215$94,06068 claims
Novo NordiskOzempic, Rybelsus$1,591$65,12233 claims
AstraZenecaFarxiga, Breztri Aerosphere$2,602$60,29466 claims
GSKTrelegy Ellipta$1,185$37,04921 claims
Boehringer IngelheimJardiance$811$28,36221 claims
PfizerEliquis$882$18,60423 claims
MerckJanuvia$74$17,25413 claims
AbbVieSynthroid$1,459$76514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →